Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dynamic Biotechnology & Genome Invesco ETF (PBE)

Dynamic Biotechnology & Genome Invesco ETF (PBE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Invesco
  • Assets Under Management 222,317,500
  • Market Capitalization, $K 222,318
  • Shares Outstanding, K 4,250
  • 60-Month Beta 1.43
  • Price/Earnings ttm 38.97
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.002 on 09/24/18
  • Management Fee 0.57%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.71 +7.16%
on 10/21/19
52.62 -0.80%
on 11/04/19
+3.59 (+7.38%)
since 10/18/19
3-Month
45.74 +14.12%
on 10/02/19
52.62 -0.80%
on 11/04/19
+0.72 (+1.40%)
since 08/16/19
52-Week
43.17 +20.92%
on 12/24/18
56.65 -7.86%
on 03/04/19
+1.06 (+2.07%)
since 11/16/18

Most Recent Stories

More News
Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks

Decent fundamentals and valuations as well as encouraging developments put these medical ETFs and stocks in focus.

PTH : 84.51 (+0.43%)
PBE : 52.20 (-0.11%)
XBI : 85.03 (+0.28%)
CNCR : 21.43 (+0.56%)
DXCM : 213.78 (+2.60%)
CLVS : 7.06 (+10.66%)
BIIB : 282.62 (+0.12%)
PTI : 1.08 (+2.86%)
AQST : 5.41 (-9.83%)
FTSV : 10.23 (-4.30%)
ARKG : 31.57 (-0.43%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 52.20 (-0.11%)
IBB : 111.24 (-0.23%)
XBI : 85.03 (+0.28%)
CELG : 109.32 (-0.64%)
VRTX : 210.00 (+0.10%)
BIIB : 282.62 (+0.12%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 52.20 (-0.11%)
IBB : 111.24 (-0.23%)
XBI : 85.03 (+0.28%)
CELG : 109.32 (-0.64%)
GILD : 64.29 (-1.20%)
BIIB : 282.62 (+0.12%)
ETFs Poised to Benefit from Gene Editing Revolution

Rising investments and growing technological advancement are favoring the genomic editing space. We take a look at a few ETFs that can cash in on this trend.

AGN : 184.50 (+0.48%)
PBE : 52.20 (-0.11%)
ONCE : 111.15 (+0.31%)
EDIT : 23.15 (+1.27%)
ARKG : 31.57 (-0.43%)
GNOM : 13.95 (+0.14%)
IDNA : 27.04 (+0.60%)
ETFs to Gain From the Booming Genomics Market

Rising investments, surging demand for personalized medicines and shrinking sequencing costs are a slew of factors favouring the genomics space. We look at a few ETFs that can cash in on this trend.

PBE : 52.20 (-0.11%)
ILMN : 306.67 (+0.22%)
IDNA : 27.04 (+0.60%)
GNOM : 13.95 (+0.14%)
ARKG : 31.57 (-0.43%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 52.20 (-0.11%)
IBB : 111.24 (-0.23%)
XBI : 85.03 (+0.28%)
INCY : 87.49 (+0.91%)
VRTX : 210.00 (+0.10%)
AMGN : 220.67 (-0.09%)
Amgen to Buy Celgene's Otezla: 5 ETF Drugs

Amgen agreed to buy psoriasis and psoriatic arthritis drug Otezla from Celgene for $13.4 billion in cash.

NVS : 90.33 (+0.32%)
BMY : 57.65 (-1.60%)
BBH : 133.65 (-0.25%)
PJP : 61.06 (+0.33%)
IBB : 111.24 (-0.23%)
PBE : 52.20 (-0.11%)
CELG : 109.32 (-0.64%)
AMGN : 220.67 (-0.09%)
IEIH : 26.44 (-0.16%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 52.20 (-0.11%)
IBB : 111.24 (-0.23%)
XBI : 85.03 (+0.28%)
TECH : 211.42 (-0.48%)
AMGN : 220.67 (-0.09%)
BIIB : 282.62 (+0.12%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 52.20 (-0.11%)
IBB : 111.24 (-0.23%)
XBI : 85.03 (+0.28%)
TECH : 211.42 (-0.48%)
INCY : 87.49 (+0.91%)
AMGN : 220.67 (-0.09%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 52.20 (-0.11%)
IBB : 111.24 (-0.23%)
XBI : 85.03 (+0.28%)
QGEN : 41.05 (+1.21%)
CELG : 109.32 (-0.64%)
ILMN : 306.67 (+0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade PBE with:

Fund Summary

The Invesco Dynamic Biotechnology and Genome ETF is based on the Dynamic Biotech and Genome Intellidex Index. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating...

See More

Key Turning Points

2nd Resistance Point 52.67
1st Resistance Point 52.46
Last Price 52.20
1st Support Level 51.89
2nd Support Level 51.52

See More

52-Week High 56.65
Last Price 52.20
Fibonacci 61.8% 51.50
Fibonacci 50% 49.91
Fibonacci 38.2% 48.32
52-Week Low 43.17

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar